Tetratherix Ltd has released a press release.
Tetratherix: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Tetratherix
- TetraDerm Cohort 1 Results
- Quarterly Activities/Appendix 4C Cash Flow Report
- Executed Henry Schein Agreement
- TetraDerm Cohort 2
- Q1FY26 Quarterly Activities Report/Appendix 4C
Later from Tetratherix
- Tutelix Update
- Precision medicine franchise launch and new revenue
- Successful Completion $15M Placement
- Appendix 4E and Annual Report 2026
Follow Tetratherix into a list and get an email when it puts out news.
Follow Tetratherix